# Ovid Therapeutics Inc.: Form 8-K, filed Nov 3, 2023

- Company: [Ovid Therapeutics Inc.](/companies/ovid.md) (CIK 1636651)
- Form: 8-K
- Filed: 2023-11-03
- Accepted by EDGAR: Nov 3, 2023, 08:10 ET
- Period: 2023-11-03
- Accession: 0001628280-23-036563
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1636651/000162828023036563/ovid-20231103.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1636651/000162828023036563/

## Items reported

- Item 2.02: Results of operations
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1636651/000162828023036563/ovid-20231103.htm

Filed Nov 3, 2023.
Source: SEC EDGAR, the filing index for accession 0001628280-23-036563. Last ingested by Listed: Oct 24, 2026, 15:14 ET. No prices; not investment advice.